| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * |
KEGG DRUG * |
DrugBank |
指定難病告示番号 * |
| 1 | Acute myeloid leukemia 3 genes, 4 drugs (DrugBank) and 40 diseases shown |
1件: KIT |
D10229 |
Masitinib |
6件: 2, 5, 6, 13, 46, 96 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: RARA |
D01418 |
Tamibarotene |
2件: 26, 96 |
| 2 | Adherens junction 2 genes, 2 drugs (DrugBank) and 7 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 3 | Adipocytokine signaling pathway 3 genes, 9 drugs (DrugBank) and 68 diseases shown |
1件: JAK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 4 | Adrenergic signaling in cardiomyocytes 11 genes, 4 drugs (DrugBank) and 29 diseases shown |
5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| 1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 1件: SCN5A |
D01450 |
Bupivacaine |
7件: 46, 53, 70, 96, 168, 226, 298 |
| D07552 |
| 5 | African trypanosomiasis 3 genes, 7 drugs (DrugBank) and 45 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 6 | AGE-RAGE signaling pathway in diabetic complications 3 genes, 8 drugs (DrugBank) and 54 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 1件: JAK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 7 | Alcoholism 18 genes, 4 drugs (DrugBank) and 10 diseases shown |
1件: ADORA2A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 11件: HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9 |
D06320 |
Vorinostat |
2件: 19, 96 |
| 1件: SLC6A3 |
D00817 |
Bupropion |
2件: 8, 96 |
| D07591 |
| D07938 |
| 8 | Aldosterone synthesis and secretion 6 genes, 3 drugs (DrugBank) and 23 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 1件: PDE2A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 9 | Aldosterone-regulated sodium reabsorption 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 10 | Allograft rejection 25 genes, 9 drugs (DrugBank) and 52 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 11 | Alzheimer disease 15 genes, 9 drugs (DrugBank) and 64 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 12 | Amoebiasis 3 genes, 7 drugs (DrugBank) and 45 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 13 | Amphetamine addiction 15 genes, 5 drugs (DrugBank) and 38 diseases shown |
2件: CACNA1C, CACNA1D |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 2件: HDAC1, HDAC2 |
D06320 |
Vorinostat |
2件: 19, 96 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: SLC6A3 |
D00817 |
Bupropion |
2件: 8, 96 |
| D07591 |
| D07938 |
| 14 | AMPK signaling pathway 6 genes, 9 drugs (DrugBank) and 59 diseases shown |
1件: ADRA1A |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| 1件: HMGCR |
D00887 |
Atorvastatin |
17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
| D07474 |
| D00893 |
Pravastatin |
9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 |
| D08410 |
| D01915 |
Rosuvastatin |
8件: 6, 46, 49, 51, 79, 96, 271, 299 |
| D08492 |
| 1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| 15 | Amyotrophic lateral sclerosis (ALS) 11 genes, 8 drugs (DrugBank) and 61 diseases shown |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 16 | Antifolate resistance 3 genes, 7 drugs (DrugBank) and 55 diseases shown |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
| D02115 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 17 | Antigen processing and presentation 21 genes, 7 drugs (DrugBank) and 45 diseases shown |
20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 18 | Apelin signaling pathway 5 genes, 5 drugs (DrugBank) and 48 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 2件: HDAC4, HDAC5 |
D06320 |
Vorinostat |
2件: 19, 96 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: PDE3B |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 19 | Apoptosis 1 gene, 6 drugs (DrugBank) and 43 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 20 | Arachidonic acid metabolism 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 21 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) 6 genes, 4 drugs (DrugBank) and 10 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 1件: ITGA4 |
D06886 |
Natalizumab |
6件: 13, 15, 25, 46, 63, 96 |
| 2件: ITGA4, ITGB7 |
D08083 |
Vedolizumab |
2件: 96, 97 |
| 1件: ITGB7 |
D09901 |
Etrolizumab |
2件: 96, 97 |
| 22 | Asthma 15 genes, 7 drugs (DrugBank) and 45 diseases shown |
14件: HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 23 | Autoimmune thyroid disease 23 genes, 3 drugs (DrugBank) and 26 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| 1件: CTLA4 |
D06657 |
Tremelimumab |
2件: 65, 96 |
| 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 24 | Autophagy - animal 2 genes, 3 drugs (DrugBank) and 41 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 25 | Autophagy - other 1 gene, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 26 | Axon guidance 5 genes, 1 drug (DrugBank) and 30 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 27 | B cell receptor signaling pathway 5 genes, 1 drug (DrugBank) and 30 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 28 | Bile secretion 2 genes, 5 drugs (DrugBank) and 28 diseases shown |
1件: HMGCR |
D00887 |
Atorvastatin |
17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
| D07474 |
| D00893 |
Pravastatin |
9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 |
| D08410 |
| D01915 |
Rosuvastatin |
8件: 6, 46, 49, 51, 79, 96, 271, 299 |
| D08492 |
| 1件: NR1H4 |
D00163 |
Chenodeoxycholic acid |
4件: 20, 96, 234, 263 |
| D00734 |
Ursodeoxycholic acid |
12件: 6, 8, 20, 67, 84, 93, 94, 95, 96, 97, 234, 299 |
| 29 | Breast cancer 6 genes, 6 drugs (DrugBank) and 50 diseases shown |
2件: ESR1, ESR2 |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
| 1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 1件: KIT |
D10229 |
Masitinib |
6件: 2, 5, 6, 13, 46, 96 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: TNFSF11 |
D03684 |
Denosumab |
7件: 46, 50, 93, 95, 96, 274, 299 |
| 30 | C-type lectin receptor signaling pathway 10 genes, 12 drugs (DrugBank) and 62 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: IL23A |
D10438 |
Guselkumab |
3件: 37, 96, 97 |
| D11123 |
Mirikizumab |
2件: 96, 97 |
| D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 31 | Caffeine metabolism 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: XDH |
D00224 |
Allopurinol |
6件: 6, 46, 57, 66, 96, 97 |
| 32 | Calcium signaling pathway 24 genes, 9 drugs (DrugBank) and 47 diseases shown |
2件: ADORA2A, PDE1B |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 6件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| 1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 4件: GRIN1, GRIN2A, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 1件: HRH1 |
D00480 |
Promethazine |
1件: 96 |
| D00494 |
| D01242 |
| D03290 |
| 1件: HTR4 |
D08236 |
Mosapride |
1件: 96 |
| D09205 |
Prucalopride |
3件: 13, 51, 96 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 33 | cAMP signaling pathway 21 genes, 7 drugs (DrugBank) and 25 diseases shown |
8件: ADORA1, ADORA2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 2件: ADRB1, ADRB2 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 1件: HTR4 |
D08236 |
Mosapride |
1件: 96 |
| D09205 |
Prucalopride |
3件: 13, 51, 96 |
| 1件: SSTR2 |
D00442 |
Octreotide |
8件: 67, 75, 84, 85, 89, 96, 193, 227 |
| D06495 |
| 34 | Carbohydrate digestion and absorption 1 gene, 1 drug (DrugBank) and 4 diseases shown |
1件: CACNA1D |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 35 | Cardiac muscle contraction 4 genes, 1 drug (DrugBank) and 4 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 36 | Cell adhesion molecules (CAMs) 27 genes, 8 drugs (DrugBank) and 33 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| 1件: CTLA4 |
D06657 |
Tremelimumab |
2件: 65, 96 |
| 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 1件: ITGA4 |
D06886 |
Natalizumab |
6件: 13, 15, 25, 46, 63, 96 |
| 2件: ITGA4, ITGB7 |
D08083 |
Vedolizumab |
2件: 96, 97 |
| 1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 1件: ITGB7 |
D09901 |
Etrolizumab |
2件: 96, 97 |
| 1件: PDCD1 |
D10316 |
Nivolumab |
10件: 13, 26, 41, 46, 49, 50, 51, 53, 96, 97 |
| 37 | Cell cycle 2 genes, 1 drug (DrugBank) and 2 diseases shown |
2件: HDAC1, HDAC2 |
D06320 |
Vorinostat |
2件: 19, 96 |
| 38 | Cellular senescence 13 genes, 5 drugs (DrugBank) and 53 diseases shown |
1件: CACNA1D |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 6件: HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 39 | Central carbon metabolism in cancer 2 genes, 3 drugs (DrugBank) and 39 diseases shown |
1件: KIT |
D10229 |
Masitinib |
6件: 2, 5, 6, 13, 46, 96 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 40 | cGMP-PKG signaling pathway 26 genes, 8 drugs (DrugBank) and 59 diseases shown |
5件: ADORA1, PDE2A, PDE3A, PDE3B, PDE5A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| 1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 1件: OPRD1 |
D02095 |
Naltrexone |
11件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97 |
| D05113 |
| 1件: PDE5A |
D02229 |
Sildenafil |
16件: 6, 46, 50, 51, 85, 86, 96, 113, 210, 211, 212, 225, 226, 278, 294, 299 |
| D08514 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 41 | Chagas disease (American trypanosomiasis) 6 genes, 9 drugs (DrugBank) and 46 diseases shown |
3件: CD3D, CD3E, CD3G |
D05092 |
Muromonab |
3件: 60, 96, 97 |
| D06314 |
Visilizumab |
2件: 96, 97 |
| 2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 42 | Chemical carcinogenesis 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 43 | Chemokine signaling pathway 2 genes, 1 drug (DrugBank) and 9 diseases shown |
2件: JAK2, JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 44 | Choline metabolism in cancer 1 gene, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 45 | Cholinergic synapse 5 genes, 2 drugs (DrugBank) and 12 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 1件: JAK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 46 | Chronic myeloid leukemia 2 genes, 1 drug (DrugBank) and 2 diseases shown |
2件: HDAC1, HDAC2 |
D06320 |
Vorinostat |
2件: 19, 96 |
| 47 | Circadian entrainment 7 genes, 2 drugs (DrugBank) and 12 diseases shown |
2件: CACNA1C, CACNA1D |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 48 | Cocaine addiction 6 genes, 2 drugs (DrugBank) and 9 diseases shown |
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 1件: SLC6A3 |
D00817 |
Bupropion |
2件: 8, 96 |
| D07591 |
| D07938 |
| 49 | Collecting duct acid secretion 2 genes, 1 drug (DrugBank) and 15 diseases shown |
2件: ATP4A, ATP4B |
D00455 |
Omeprazole |
15件: 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| D01207 |
| D05259 |
| D05261 |
| 50 | Colorectal cancer 1 gene, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 51 | Complement and coagulation cascades 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: F10 |
D03213 |
Apixaban |
2件: 96, 97 |
| 52 | Cortisol synthesis and secretion 5 genes, 2 drugs (DrugBank) and 20 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 53 | Cushing syndrome 5 genes, 2 drugs (DrugBank) and 20 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 54 | Cytokine-cytokine receptor interaction 12 genes, 19 drugs (DrugBank) and 73 diseases shown |
1件: CSF2RA |
D05803 |
Sargramostim |
6件: 6, 28, 60, 62, 96, 229 |
| 1件: CSF3R |
D03235 |
Filgrastim |
28件: 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
| 1件: EPOR |
D03231 |
Erythropoietin |
9件: 2, 6, 13, 22, 46, 47, 70, 95, 96 |
| 1件: GHR |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| D02691 |
Somatotropin |
18件: 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| 2件: IFNAR1, IFNAR2 |
D03305 |
Interferon alfa |
5件: 25, 26, 28, 56, 96 |
| D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
| 1件: IL11RA |
D05266 |
Oprelvekin |
2件: 96, 288 |
| 3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: IL23A |
D10438 |
Guselkumab |
3件: 37, 96, 97 |
| D11123 |
Mirikizumab |
2件: 96, 97 |
| D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 1件: TNFSF11 |
D03684 |
Denosumab |
7件: 46, 50, 93, 95, 96, 274, 299 |
| 55 | Dilated cardiomyopathy (DCM) 8 genes, 11 drugs (DrugBank) and 55 diseases shown |
1件: ADRB1 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 1件: ITGA4 |
D06886 |
Natalizumab |
6件: 13, 15, 25, 46, 63, 96 |
| 2件: ITGA4, ITGB7 |
D08083 |
Vedolizumab |
2件: 96, 97 |
| 1件: ITGB7 |
D09901 |
Etrolizumab |
2件: 96, 97 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 56 | DNA replication 2 genes, 1 drug (DrugBank) and 9 diseases shown |
2件: POLA1, POLA2 |
D03546 |
Clofarabine |
9件: 19, 20, 40, 46, 49, 60, 96, 234, 326 |
| 57 | Dopaminergic synapse 9 genes, 5 drugs (DrugBank) and 40 diseases shown |
2件: CACNA1C, CACNA1D |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 2件: GRIN2A, GRIN2B |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 3件: PPP3CA, PPP3CB, PPP3CC |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: SCN1A |
D01450 |
Bupivacaine |
7件: 46, 53, 70, 96, 168, 226, 298 |
| D07552 |
| 1件: SLC6A3 |
D00817 |
Bupropion |
2件: 8, 96 |
| D07591 |
| D07938 |
| 58 | Drug metabolism - other enzymes 5 genes, 6 drugs (DrugBank) and 43 diseases shown |
1件: HPRT1 |
D00161 |
Mercaptopurine |
5件: 86, 94, 96, 97, 164 |
| D04931 |
| 2件: IMPDH1, IMPDH2 |
D00752 |
Mycophenolate mofetil |
32件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
| D05094 |
| D05095 |
| D05096 |
Mycophenolic acid |
34件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
| 1件: RRM1 |
D03546 |
Clofarabine |
9件: 19, 20, 40, 46, 49, 60, 96, 234, 326 |
| D01907 |
Fludarabine |
17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
| D07966 |
| 1件: XDH |
D00224 |
Allopurinol |
6件: 6, 46, 57, 66, 96, 97 |
| 59 | ECM-receptor interaction 2 genes, 3 drugs (DrugBank) and 7 diseases shown |
1件: ITGA4 |
D06886 |
Natalizumab |
6件: 13, 15, 25, 46, 63, 96 |
| 2件: ITGA4, ITGB7 |
D08083 |
Vedolizumab |
2件: 96, 97 |
| 1件: ITGB7 |
D09901 |
Etrolizumab |
2件: 96, 97 |
| 60 | EGFR tyrosine kinase inhibitor resistance 4 genes, 6 drugs (DrugBank) and 48 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, JAK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 61 | Endocrine and other factor-regulated calcium reabsorption 2 genes, 5 drugs (DrugBank) and 26 diseases shown |
1件: ESR1 |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
| 1件: VDR |
D01518 |
Alfacalcidol |
6件: 41, 46, 49, 50, 96, 235 |
| D00129 |
Calcitriol |
8件: 37, 46, 49, 66, 96, 158, 235, 326 |
| D00188 |
Cholecalciferol |
15件: 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
| D00187 |
Ergocalciferol |
5件: 46, 84, 96, 97, 299 |
| 62 | Endocrine resistance 4 genes, 4 drugs (DrugBank) and 44 diseases shown |
2件: ESR1, ESR2 |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
| 1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 63 | Endocytosis 7 genes, 2 drugs (DrugBank) and 9 diseases shown |
6件: HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 64 | Epstein-Barr virus infection 32 genes, 16 drugs (DrugBank) and 51 diseases shown |
3件: CD3D, CD3E, CD3G |
D05092 |
Muromonab |
3件: 60, 96, 97 |
| D06314 |
Visilizumab |
2件: 96, 97 |
| 2件: HDAC1, HDAC2 |
D06320 |
Vorinostat |
2件: 19, 96 |
| 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 2件: IFNAR1, IFNAR2 |
D03305 |
Interferon alfa |
5件: 25, 26, 28, 56, 96 |
| D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
| 1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 3件: JAK1, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 65 | ErbB signaling pathway 1 gene, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 66 | Estrogen signaling pathway 4 genes, 3 drugs (DrugBank) and 17 diseases shown |
2件: ESR1, ESR2 |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
| 1件: OPRM1 |
D02095 |
Naltrexone |
11件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97 |
| D05113 |
| 1件: RARA |
D01418 |
Tamibarotene |
2件: 26, 96 |
| 67 | Fc epsilon RI signaling pathway 1 gene, 6 drugs (DrugBank) and 43 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 68 | Fluid shear stress and atherosclerosis 2 genes, 7 drugs (DrugBank) and 48 diseases shown |
1件: NQO1 |
D00564 |
Warfarin |
10件: 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
| D01280 |
| D08682 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 69 | Focal adhesion 3 genes, 4 drugs (DrugBank) and 12 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 1件: ITGA4 |
D06886 |
Natalizumab |
6件: 13, 15, 25, 46, 63, 96 |
| 2件: ITGA4, ITGB7 |
D08083 |
Vedolizumab |
2件: 96, 97 |
| 1件: ITGB7 |
D09901 |
Etrolizumab |
2件: 96, 97 |
| 70 | Folate biosynthesis 2 genes, 1 drug (DrugBank) and 33 diseases shown |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
| D02115 |
| 71 | FoxO signaling pathway 4 genes, 3 drugs (DrugBank) and 9 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 2件: S1PR1, S1PR4 |
D10968 |
Ozanimod |
3件: 13, 96, 97 |
| 72 | GABAergic synapse 20 genes, 2 drugs (DrugBank) and 13 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
10件: 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
| D00696 |
| D05028 |
| 73 | Gap junction 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: ADRB1 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| 74 | Gastric acid secretion 3 genes, 2 drugs (DrugBank) and 21 diseases shown |
2件: ATP4A, ATP4B |
D00455 |
Omeprazole |
15件: 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| D01207 |
| D05259 |
| D05261 |
| 1件: SSTR2 |
D00442 |
Octreotide |
8件: 67, 75, 84, 85, 89, 96, 193, 227 |
| D06495 |
| 75 | Gastric cancer 1 gene, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 76 | Glioma 2 genes, 3 drugs (DrugBank) and 41 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 77 | Glucagon signaling pathway 6 genes, 2 drugs (DrugBank) and 32 diseases shown |
1件: PDE3B |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 78 | Glutamatergic synapse 12 genes, 3 drugs (DrugBank) and 37 diseases shown |
2件: CACNA1C, CACNA1D |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 79 | Glutathione metabolism 1 gene, 2 drugs (DrugBank) and 21 diseases shown |
1件: RRM1 |
D03546 |
Clofarabine |
9件: 19, 20, 40, 46, 49, 60, 96, 234, 326 |
| D01907 |
Fludarabine |
17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
| D07966 |
| 80 | GnRH secretion 5 genes, 2 drugs (DrugBank) and 9 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 1件: ESR2 |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
| 81 | GnRH signaling pathway 4 genes, 1 drug (DrugBank) and 4 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 82 | Graft-versus-host disease 23 genes, 8 drugs (DrugBank) and 52 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 83 | Growth hormone synthesis, secretion and action 8 genes, 7 drugs (DrugBank) and 61 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 1件: GHR |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| D02691 |
Somatotropin |
18件: 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| 1件: JAK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: SSTR2 |
D00442 |
Octreotide |
8件: 67, 75, 84, 85, 89, 96, 193, 227 |
| D06495 |
| 84 | Hematopoietic cell lineage 25 genes, 17 drugs (DrugBank) and 75 diseases shown |
3件: CD3D, CD3E, CD3G |
D05092 |
Muromonab |
3件: 60, 96, 97 |
| D06314 |
Visilizumab |
2件: 96, 97 |
| 1件: CSF2RA |
D05803 |
Sargramostim |
6件: 6, 28, 60, 62, 96, 229 |
| 1件: CSF3R |
D03235 |
Filgrastim |
28件: 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
| 1件: EPOR |
D03231 |
Erythropoietin |
9件: 2, 6, 13, 22, 46, 47, 70, 95, 96 |
| 14件: HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 1件: IL11RA |
D05266 |
Oprelvekin |
2件: 96, 288 |
| 1件: ITGA4 |
D06886 |
Natalizumab |
6件: 13, 15, 25, 46, 63, 96 |
| D08083 |
Vedolizumab |
2件: 96, 97 |
| 1件: KIT |
D10229 |
Masitinib |
6件: 2, 5, 6, 13, 46, 96 |
| 1件: MS4A1 |
D02994 |
Rituximab |
42件: 11, 13, 14, 17, 35, 36, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 223, 229, 256, 271, 283, 284, 285, 288, 300, 331 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 85 | Hepatitis B 6 genes, 11 drugs (DrugBank) and 47 diseases shown |
1件: IFNAR1 |
D03305 |
Interferon alfa |
5件: 25, 26, 28, 56, 96 |
| D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 4件: JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 86 | Hepatitis C 5 genes, 11 drugs (DrugBank) and 47 diseases shown |
2件: IFNAR1, IFNAR2 |
D03305 |
Interferon alfa |
5件: 25, 26, 28, 56, 96 |
| D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 87 | Hepatocellular carcinoma 3 genes, 4 drugs (DrugBank) and 45 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: NQO1 |
D00564 |
Warfarin |
10件: 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
| D01280 |
| D08682 |
| 88 | Herpes simplex virus 1 infection 29 genes, 15 drugs (DrugBank) and 72 diseases shown |
20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 2件: IFNAR1, IFNAR2 |
D03305 |
Interferon alfa |
5件: 25, 26, 28, 56, 96 |
| D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
| 2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 3件: JAK1, JAK2, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 89 | HIF-1 signaling pathway 3 genes, 4 drugs (DrugBank) and 42 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 90 | Hippo signaling pathway 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: SMAD7 |
D10956 |
Mongersen |
2件: 96, 97 |
| 91 | Human cytomegalovirus infection 15 genes, 14 drugs (DrugBank) and 76 diseases shown |
6件: HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 92 | Human immunodeficiency virus 1 infection 16 genes, 12 drugs (DrugBank) and 72 diseases shown |
3件: CD3D, CD3E, CD3G |
D05092 |
Muromonab |
3件: 60, 96, 97 |
| D06314 |
Visilizumab |
2件: 96, 97 |
| 6件: HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 93 | Human papillomavirus infection 17 genes, 19 drugs (DrugBank) and 74 diseases shown |
2件: HDAC1, HDAC2 |
D06320 |
Vorinostat |
2件: 19, 96 |
| 6件: HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 2件: IFNAR1, IFNAR2 |
D03305 |
Interferon alfa |
5件: 25, 26, 28, 56, 96 |
| D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
| 1件: ITGA4 |
D06886 |
Natalizumab |
6件: 13, 15, 25, 46, 63, 96 |
| 2件: ITGA4, ITGB7 |
D08083 |
Vedolizumab |
2件: 96, 97 |
| 1件: ITGB7 |
D09901 |
Etrolizumab |
2件: 96, 97 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 94 | Human T-cell leukemia virus 1 infection 33 genes, 16 drugs (DrugBank) and 63 diseases shown |
3件: CD3D, CD3E, CD3G |
D05092 |
Muromonab |
3件: 60, 96, 97 |
| D06314 |
Visilizumab |
2件: 96, 97 |
| 1件: FDPS |
D00942 |
Risedronic acid |
7件: 46, 66, 93, 95, 96, 113, 274 |
| D03234 |
| D08484 |
| D01968 |
Zoledronic acid |
11件: 6, 13, 46, 65, 93, 95, 96, 271, 274, 299, 333 |
| D06378 |
| D06379 |
| D08689 |
| 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 95 | Huntington disease 5 genes, 3 drugs (DrugBank) and 21 diseases shown |
2件: GRIN1, GRIN2B |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 2件: HDAC1, HDAC2 |
D06320 |
Vorinostat |
2件: 19, 96 |
| 1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| 96 | Hypertrophic cardiomyopathy (HCM) 7 genes, 10 drugs (DrugBank) and 50 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 1件: ITGA4 |
D06886 |
Natalizumab |
6件: 13, 15, 25, 46, 63, 96 |
| 2件: ITGA4, ITGB7 |
D08083 |
Vedolizumab |
2件: 96, 97 |
| 1件: ITGB7 |
D09901 |
Etrolizumab |
2件: 96, 97 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 97 | IL-17 signaling pathway 2 genes, 7 drugs (DrugBank) and 47 diseases shown |
1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 98 | Inflammatory bowel disease (IBD) 18 genes, 11 drugs (DrugBank) and 46 diseases shown |
14件: HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: IL23A |
D10438 |
Guselkumab |
3件: 37, 96, 97 |
| D11123 |
Mirikizumab |
2件: 96, 97 |
| D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 99 | Inflammatory mediator regulation of TRP channels 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: HRH1 |
D00480 |
Promethazine |
1件: 96 |
| D00494 |
| D01242 |
| D03290 |
| 100 | Influenza A 23 genes, 15 drugs (DrugBank) and 55 diseases shown |
1件: FDPS |
D00942 |
Risedronic acid |
7件: 46, 66, 93, 95, 96, 113, 274 |
| D03234 |
| D08484 |
| D01968 |
Zoledronic acid |
11件: 6, 13, 46, 65, 93, 95, 96, 271, 274, 299, 333 |
| D06378 |
| D06379 |
| D08689 |
| 14件: HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 2件: IFNAR1, IFNAR2 |
D03305 |
Interferon alfa |
5件: 25, 26, 28, 56, 96 |
| D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
| 2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 3件: JAK1, JAK2, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 101 | Insulin resistance 3 genes, 9 drugs (DrugBank) and 68 diseases shown |
1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 102 | Insulin secretion 4 genes, 1 drug (DrugBank) and 4 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 103 | Insulin signaling pathway 3 genes, 4 drugs (DrugBank) and 41 diseases shown |
1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: PDE3B |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 104 | Intestinal immune network for IgA production 18 genes, 5 drugs (DrugBank) and 29 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| 14件: HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 1件: ITGA4 |
D06886 |
Natalizumab |
6件: 13, 15, 25, 46, 63, 96 |
| 2件: ITGA4, ITGB7 |
D08083 |
Vedolizumab |
2件: 96, 97 |
| 1件: ITGB7 |
D09901 |
Etrolizumab |
2件: 96, 97 |
| 105 | JAK-STAT signaling pathway 15 genes, 17 drugs (DrugBank) and 81 diseases shown |
1件: CSF2RA |
D05803 |
Sargramostim |
6件: 6, 28, 60, 62, 96, 229 |
| 1件: CSF3R |
D03235 |
Filgrastim |
28件: 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
| 1件: EPOR |
D03231 |
Erythropoietin |
9件: 2, 6, 13, 22, 46, 47, 70, 95, 96 |
| 1件: GHR |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| D02691 |
Somatotropin |
18件: 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| 2件: IFNAR1, IFNAR2 |
D03305 |
Interferon alfa |
5件: 25, 26, 28, 56, 96 |
| D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
| 1件: IL11RA |
D05266 |
Oprelvekin |
2件: 96, 288 |
| 3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: IL23A |
D10438 |
Guselkumab |
3件: 37, 96, 97 |
| D11123 |
Mirikizumab |
2件: 96, 97 |
| D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 4件: JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 106 | Kaposi sarcoma-associated herpesvirus infection 19 genes, 11 drugs (DrugBank) and 67 diseases shown |
1件: CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| 6件: HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 2件: IFNAR1, IFNAR2 |
D03305 |
Interferon alfa |
5件: 25, 26, 28, 56, 96 |
| D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 3件: JAK1, JAK2, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 107 | Legionellosis 3 genes, 7 drugs (DrugBank) and 45 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 108 | Leishmaniasis 21 genes, 14 drugs (DrugBank) and 54 diseases shown |
14件: HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: ITGA4 |
D06886 |
Natalizumab |
6件: 13, 15, 25, 46, 63, 96 |
| D08083 |
Vedolizumab |
2件: 96, 97 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, JAK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 109 | Leukocyte transendothelial migration 2 genes, 3 drugs (DrugBank) and 13 diseases shown |
1件: ITGA4 |
D06886 |
Natalizumab |
6件: 13, 15, 25, 46, 63, 96 |
| D08083 |
Vedolizumab |
2件: 96, 97 |
| 1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 110 | Long-term depression 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 111 | Long-term potentiation 11 genes, 3 drugs (DrugBank) and 37 diseases shown |
1件: CACNA1C |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 112 | Longevity regulating pathway 4 genes, 5 drugs (DrugBank) and 47 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| 113 | Longevity regulating pathway - multiple species 5 genes, 5 drugs (DrugBank) and 43 diseases shown |
2件: HDAC1, HDAC2 |
D06320 |
Vorinostat |
2件: 19, 96 |
| 1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 114 | Malaria 3 genes, 8 drugs (DrugBank) and 47 diseases shown |
1件: IL12A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 115 | MAPK signaling pathway 13 genes, 11 drugs (DrugBank) and 66 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 1件: KIT |
D10229 |
Masitinib |
6件: 2, 5, 6, 13, 46, 96 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 116 | Measles 10 genes, 8 drugs (DrugBank) and 24 diseases shown |
3件: CD3D, CD3E, CD3G |
D05092 |
Muromonab |
3件: 60, 96, 97 |
| D06314 |
Visilizumab |
2件: 96, 97 |
| 2件: IFNAR1, IFNAR2 |
D03305 |
Interferon alfa |
5件: 25, 26, 28, 56, 96 |
| D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
| 2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 3件: JAK1, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 117 | Melanogenesis 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: KIT |
D10229 |
Masitinib |
6件: 2, 5, 6, 13, 46, 96 |
| 118 | Melanoma 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 119 | Metabolic pathways 23 genes, 17 drugs (DrugBank) and 80 diseases shown |
2件: ATP4A, ATP4B |
D00455 |
Omeprazole |
15件: 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| D01207 |
| D05259 |
| D05261 |
| 2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
| D02115 |
| 1件: FDPS |
D00942 |
Risedronic acid |
7件: 46, 66, 93, 95, 96, 113, 274 |
| D03234 |
| D08484 |
| D01968 |
Zoledronic acid |
11件: 6, 13, 46, 65, 93, 95, 96, 271, 274, 299, 333 |
| D06378 |
| D06379 |
| D08689 |
| 1件: HMGCR |
D00887 |
Atorvastatin |
17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
| D07474 |
| D00893 |
Pravastatin |
9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 |
| D08410 |
| D01915 |
Rosuvastatin |
8件: 6, 46, 49, 51, 79, 96, 271, 299 |
| D08492 |
| 1件: HPRT1 |
D00161 |
Mercaptopurine |
5件: 86, 94, 96, 97, 164 |
| D04931 |
| 2件: IMPDH1, IMPDH2 |
D00752 |
Mycophenolate mofetil |
32件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
| D05094 |
| D05095 |
| D05096 |
Mycophenolic acid |
34件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
| 2件: NQO1, VKORC1 |
D00564 |
Warfarin |
10件: 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
| D01280 |
| D08682 |
| 9件: PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 1件: PDE5A |
D02229 |
Sildenafil |
16件: 6, 46, 50, 51, 85, 86, 96, 113, 210, 211, 212, 225, 226, 278, 294, 299 |
| D08514 |
| 1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 1件: RRM1 |
D03546 |
Clofarabine |
9件: 19, 20, 40, 46, 49, 60, 96, 234, 326 |
| D01907 |
Fludarabine |
17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
| D07966 |
| 1件: XDH |
D00224 |
Allopurinol |
6件: 6, 46, 57, 66, 96, 97 |
| 120 | MicroRNAs in cancer 6 genes, 4 drugs (DrugBank) and 42 diseases shown |
4件: HDAC1, HDAC2, HDAC4, HDAC5 |
D06320 |
Vorinostat |
2件: 19, 96 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 121 | Mineral absorption 1 gene, 4 drugs (DrugBank) and 23 diseases shown |
1件: VDR |
D01518 |
Alfacalcidol |
6件: 41, 46, 49, 50, 96, 235 |
| D00129 |
Calcitriol |
8件: 37, 46, 49, 66, 96, 158, 235, 326 |
| D00188 |
Cholecalciferol |
15件: 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
| D00187 |
Ergocalciferol |
5件: 46, 84, 96, 97, 299 |
| 122 | Morphine addiction 26 genes, 3 drugs (DrugBank) and 18 diseases shown |
9件: ADORA1, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
10件: 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
| D00696 |
| D05028 |
| 1件: OPRM1 |
D02095 |
Naltrexone |
11件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97 |
| D05113 |
| 123 | mTOR signaling pathway 4 genes, 10 drugs (DrugBank) and 72 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 124 | Natural killer cell mediated cytotoxicity 14 genes, 11 drugs (DrugBank) and 60 diseases shown |
5件: HLA-A, HLA-B, HLA-C, HLA-E, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 2件: IFNAR1, IFNAR2 |
D03305 |
Interferon alfa |
5件: 25, 26, 28, 56, 96 |
| D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
| 1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 125 | Necroptosis 7 genes, 11 drugs (DrugBank) and 47 diseases shown |
2件: IFNAR1, IFNAR2 |
D03305 |
Interferon alfa |
5件: 25, 26, 28, 56, 96 |
| D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 4件: JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 126 | Neuroactive ligand-receptor interaction 49 genes, 22 drugs (DrugBank) and 95 diseases shown |
2件: ADORA1, ADORA2A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| 1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 2件: CNR1, CNR2 |
D10915 |
Cannabidiol |
14件: 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
| 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
10件: 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
| D00696 |
| D05028 |
| 1件: GHR |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| D02691 |
Somatotropin |
18件: 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| 1件: GLP2R |
D06053 |
Teduglutide |
1件: 96 |
| 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 1件: HRH1 |
D00480 |
Promethazine |
1件: 96 |
| D00494 |
| D01242 |
| D03290 |
| 1件: HTR4 |
D08236 |
Mosapride |
1件: 96 |
| D09205 |
Prucalopride |
3件: 13, 51, 96 |
| 1件: NR3C1 |
D00244 |
Betamethasone |
6件: 2, 46, 65, 90, 96, 235 |
| D00972 |
| D01357 |
| D01402 |
| D01637 |
| D02032 |
| D02286 |
| D00246 |
Budesonide |
10件: 66, 85, 93, 94, 95, 96, 97, 98, 228, 299 |
| D00292 |
Dexamethasone |
20件: 13, 16, 28, 35, 46, 53, 63, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 222, 296, 299 |
| D00975 |
| D01510 |
| D01615 |
| D01632 |
| D01948 |
| D02174 |
| D02591 |
| D02592 |
| D00407 |
Methylprednisolone |
36件: 2, 13, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 145, 164, 220, 222, 224, 271, 283, 284, 285, 296 |
| D00751 |
| D00979 |
| D05000 |
| D05001 |
| D05002 |
| D00472 |
Prednisolone |
38件: 11, 13, 25, 26, 35, 38, 39, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
| D00980 |
| D00981 |
| D00982 |
| D01239 |
| D01998 |
| D02156 |
| D03301 |
| D00473 |
Prednisone |
44件: 2, 11, 13, 14, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 95, 96, 97, 113, 145, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
| D00385 |
Triamcinolone |
18件: 6, 10, 13, 35, 40, 41, 42, 43, 44, 45, 46, 56, 70, 90, 96, 97, 226, 298 |
| D00983 |
| D00984 |
| D00985 |
| D06216 |
| 3件: OPRD1, OPRK1, OPRM1 |
D02095 |
Naltrexone |
11件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97 |
| D05113 |
| 5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 |
D10968 |
Ozanimod |
3件: 13, 96, 97 |
| 1件: SSTR2 |
D00442 |
Octreotide |
8件: 67, 75, 84, 85, 89, 96, 193, 227 |
| D06495 |
| 127 | NF-kappa B signaling pathway 3 genes, 8 drugs (DrugBank) and 50 diseases shown |
1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 1件: TNFSF11 |
D03684 |
Denosumab |
7件: 46, 50, 93, 95, 96, 274, 299 |
| 128 | Nicotine addiction 21 genes, 2 drugs (DrugBank) and 13 diseases shown |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
10件: 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
| D00696 |
| D05028 |
| 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 129 | NOD-like receptor signaling pathway 5 genes, 11 drugs (DrugBank) and 47 diseases shown |
2件: IFNAR1, IFNAR2 |
D03305 |
Interferon alfa |
5件: 25, 26, 28, 56, 96 |
| D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 130 | Non-alcoholic fatty liver disease (NAFLD) 2 genes, 7 drugs (DrugBank) and 44 diseases shown |
1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 131 | Non-small cell lung cancer 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 132 | Notch signaling pathway 2 genes, 1 drug (DrugBank) and 2 diseases shown |
2件: HDAC1, HDAC2 |
D06320 |
Vorinostat |
2件: 19, 96 |
| 133 | Olfactory transduction 2 genes, 1 drug (DrugBank) and 6 diseases shown |
2件: PDE1B, PDE2A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 134 | One carbon pool by folate 2 genes, 1 drug (DrugBank) and 33 diseases shown |
2件: DHFR, DHFR2 |
D00142 |
Methotrexate |
33件: 11, 13, 19, 34, 35, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 162, 164, 172, 256, 271, 284, 285, 326, 331 |
| D02115 |
| 135 | Oocyte meiosis 7 genes, 3 drugs (DrugBank) and 34 diseases shown |
1件: AR |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
| 1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 136 | Osteoclast differentiation 12 genes, 14 drugs (DrugBank) and 69 diseases shown |
2件: IFNAR1, IFNAR2 |
D03305 |
Interferon alfa |
5件: 25, 26, 28, 56, 96 |
| D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 1件: TNFSF11 |
D03684 |
Denosumab |
7件: 46, 50, 93, 95, 96, 274, 299 |
| 137 | Ovarian steroidogenesis 3 genes, 3 drugs (DrugBank) and 15 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 138 | Oxidative phosphorylation 2 genes, 1 drug (DrugBank) and 15 diseases shown |
2件: ATP4A, ATP4B |
D00455 |
Omeprazole |
15件: 6, 8, 13, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| D01207 |
| D05259 |
| D05261 |
| 139 | Oxytocin signaling pathway 10 genes, 3 drugs (DrugBank) and 39 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 140 | Pancreatic cancer 2 genes, 5 drugs (DrugBank) and 44 diseases shown |
1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 141 | Parathyroid hormone synthesis, secretion and action 6 genes, 6 drugs (DrugBank) and 28 diseases shown |
4件: PDE4A, PDE4B, PDE4C, PDE4D |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 1件: TNFSF11 |
D03684 |
Denosumab |
7件: 46, 50, 93, 95, 96, 274, 299 |
| 1件: VDR |
D01518 |
Alfacalcidol |
6件: 41, 46, 49, 50, 96, 235 |
| D00129 |
Calcitriol |
8件: 37, 46, 49, 66, 96, 158, 235, 326 |
| D00188 |
Cholecalciferol |
15件: 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
| D00187 |
Ergocalciferol |
5件: 46, 84, 96, 97, 299 |
| 142 | Parkinson disease 2 genes, 2 drugs (DrugBank) and 7 diseases shown |
1件: ADORA2A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 1件: SLC6A3 |
D00817 |
Bupropion |
2件: 8, 96 |
| D07591 |
| D07938 |
| 143 | Pathogenic Escherichia coli infection 1 gene, 6 drugs (DrugBank) and 43 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 144 | Pathways in cancer 24 genes, 23 drugs (DrugBank) and 84 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 3件: AR, ESR1, ESR2 |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
| 1件: CSF2RA |
D05803 |
Sargramostim |
6件: 6, 28, 60, 62, 96, 229 |
| 1件: CSF3R |
D03235 |
Filgrastim |
28件: 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
| 1件: EPOR |
D03231 |
Erythropoietin |
9件: 2, 6, 13, 22, 46, 47, 70, 95, 96 |
| 2件: HDAC1, HDAC2 |
D06320 |
Vorinostat |
2件: 19, 96 |
| 2件: IFNAR1, IFNAR2 |
D03305 |
Interferon alfa |
5件: 25, 26, 28, 56, 96 |
| D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
| 1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: IL23A |
D10438 |
Guselkumab |
3件: 37, 96, 97 |
| D11123 |
Mirikizumab |
2件: 96, 97 |
| D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 3件: JAK1, JAK2, JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: KIT |
D10229 |
Masitinib |
6件: 2, 5, 6, 13, 46, 96 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: NQO1 |
D00564 |
Warfarin |
10件: 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
| D01280 |
| D08682 |
| 1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| 1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 1件: RARA |
D01418 |
Tamibarotene |
2件: 26, 96 |
| 145 | PD-L1 expression and PD-1 checkpoint pathway in cancer 12 genes, 9 drugs (DrugBank) and 54 diseases shown |
3件: CD3D, CD3E, CD3G |
D05092 |
Muromonab |
3件: 60, 96, 97 |
| D06314 |
Visilizumab |
2件: 96, 97 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, JAK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: PDCD1 |
D10316 |
Nivolumab |
10件: 13, 26, 41, 46, 49, 50, 51, 53, 96, 97 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 146 | Peroxisome 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: XDH |
D00224 |
Allopurinol |
6件: 6, 46, 57, 66, 96, 97 |
| 147 | Pertussis 4 genes, 10 drugs (DrugBank) and 45 diseases shown |
3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: IL23A |
D10438 |
Guselkumab |
3件: 37, 96, 97 |
| D11123 |
Mirikizumab |
2件: 96, 97 |
| D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 148 | Phagosome 20 genes, 1 drug (DrugBank) and 4 diseases shown |
20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 149 | Phospholipase D signaling pathway 4 genes, 5 drugs (DrugBank) and 49 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 1件: KIT |
D10229 |
Masitinib |
6件: 2, 5, 6, 13, 46, 96 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 150 | PI3K-Akt signaling pathway 14 genes, 16 drugs (DrugBank) and 77 diseases shown |
1件: CSF3R |
D03235 |
Filgrastim |
28件: 2, 6, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 85, 96, 113, 164, 283, 284, 285, 331 |
| 1件: EPOR |
D03231 |
Erythropoietin |
9件: 2, 6, 13, 22, 46, 47, 70, 95, 96 |
| 1件: GHR |
D02691 |
Somatotropin |
18件: 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
| 2件: GHR, IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 2件: IFNAR1, IFNAR2 |
D03305 |
Interferon alfa |
5件: 25, 26, 28, 56, 96 |
| D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
| 1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 1件: ITGA4 |
D06886 |
Natalizumab |
6件: 13, 15, 25, 46, 63, 96 |
| 2件: ITGA4, ITGB7 |
D08083 |
Vedolizumab |
2件: 96, 97 |
| 1件: ITGB7 |
D09901 |
Etrolizumab |
2件: 96, 97 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 3件: JAK1, JAK2, JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: KIT |
D10229 |
Masitinib |
6件: 2, 5, 6, 13, 46, 96 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 151 | PPAR signaling pathway 1 gene, 1 drug (DrugBank) and 17 diseases shown |
1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| 152 | Primary immunodeficiency 3 genes, 3 drugs (DrugBank) and 10 diseases shown |
2件: CD3D, CD3E |
D05092 |
Muromonab |
3件: 60, 96, 97 |
| D06314 |
Visilizumab |
2件: 96, 97 |
| 1件: JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 153 | Progesterone-mediated oocyte maturation 2 genes, 2 drugs (DrugBank) and 10 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 1件: PDE3B |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 154 | Prolactin signaling pathway 4 genes, 3 drugs (DrugBank) and 17 diseases shown |
2件: ESR1, ESR2 |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
| 1件: JAK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: TNFSF11 |
D03684 |
Denosumab |
7件: 46, 50, 93, 95, 96, 274, 299 |
| 155 | Prostate cancer 3 genes, 4 drugs (DrugBank) and 44 diseases shown |
1件: AR |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
| 1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 156 | Proteoglycans in cancer 5 genes, 11 drugs (DrugBank) and 74 diseases shown |
1件: ESR1 |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
| 1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 1件: IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 157 | Purine metabolism 14 genes, 8 drugs (DrugBank) and 53 diseases shown |
1件: HPRT1 |
D00161 |
Mercaptopurine |
5件: 86, 94, 96, 97, 164 |
| D04931 |
| 2件: IMPDH1, IMPDH2 |
D00752 |
Mycophenolate mofetil |
32件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
| D05094 |
| D05095 |
| D05096 |
Mycophenolic acid |
34件: 2, 11, 13, 14, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
| 9件: PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 1件: PDE5A |
D02229 |
Sildenafil |
16件: 6, 46, 50, 51, 85, 86, 96, 113, 210, 211, 212, 225, 226, 278, 294, 299 |
| D08514 |
| 1件: RRM1 |
D03546 |
Clofarabine |
9件: 19, 20, 40, 46, 49, 60, 96, 234, 326 |
| D01907 |
Fludarabine |
17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
| D07966 |
| 1件: XDH |
D00224 |
Allopurinol |
6件: 6, 46, 57, 66, 96, 97 |
| 158 | Pyrimidine metabolism 1 gene, 2 drugs (DrugBank) and 21 diseases shown |
1件: RRM1 |
D03546 |
Clofarabine |
9件: 19, 20, 40, 46, 49, 60, 96, 234, 326 |
| D01907 |
Fludarabine |
17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
| D07966 |
| 159 | Rap1 signaling pathway 9 genes, 7 drugs (DrugBank) and 27 diseases shown |
1件: ADORA2A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 1件: CNR1 |
D10915 |
Cannabidiol |
14件: 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
| 3件: GRIN1, GRIN2A, GRIN2B |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 1件: KIT |
D10229 |
Masitinib |
6件: 2, 5, 6, 13, 46, 96 |
| 160 | Ras signaling pathway 6 genes, 4 drugs (DrugBank) and 14 diseases shown |
3件: GRIN1, GRIN2A, GRIN2B |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 1件: KIT |
D10229 |
Masitinib |
6件: 2, 5, 6, 13, 46, 96 |
| 161 | Regulation of actin cytoskeleton 3 genes, 4 drugs (DrugBank) and 13 diseases shown |
1件: ITGA4 |
D06886 |
Natalizumab |
6件: 13, 15, 25, 46, 63, 96 |
| 2件: ITGA4, ITGB7 |
D08083 |
Vedolizumab |
2件: 96, 97 |
| 1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 1件: ITGB7 |
D09901 |
Etrolizumab |
2件: 96, 97 |
| 162 | Regulation of lipolysis in adipocytes 7 genes, 4 drugs (DrugBank) and 19 diseases shown |
2件: ADORA1, PDE3B |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 3件: ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| 1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 163 | Renin secretion 17 genes, 5 drugs (DrugBank) and 45 diseases shown |
4件: ADORA1, PDE1B, PDE3A, PDE3B |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 3件: ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| 1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 164 | Renin-angiotensin system 1 gene, 1 drug (DrugBank) and 18 diseases shown |
1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 165 | Retrograde endocannabinoid signaling 22 genes, 4 drugs (DrugBank) and 23 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 1件: CNR1 |
D10915 |
Cannabidiol |
14件: 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
| 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00550 |
Midazolam |
10件: 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
| D00696 |
| D05028 |
| 1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 166 | Rheumatoid arthritis 21 genes, 15 drugs (DrugBank) and 55 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| 1件: CTLA4 |
D06657 |
Tremelimumab |
2件: 65, 96 |
| 14件: HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 1件: IL23A |
D10438 |
Guselkumab |
3件: 37, 96, 97 |
| D11123 |
Mirikizumab |
2件: 96, 97 |
| D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
| D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 1件: TNFSF11 |
D03684 |
Denosumab |
7件: 46, 50, 93, 95, 96, 274, 299 |
| 167 | RIG-I-like receptor signaling pathway 3 genes, 7 drugs (DrugBank) and 45 diseases shown |
2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 168 | Salivary secretion 6 genes, 1 drug (DrugBank) and 9 diseases shown |
6件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, ADRB3 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| 169 | Serotonergic synapse 9 genes, 5 drugs (DrugBank) and 18 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 3件: GABRB1, GABRB2, GABRB3 |
D00550 |
Midazolam |
10件: 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
| D00696 |
| D05028 |
| 1件: HTR4 |
D08236 |
Mosapride |
1件: 96 |
| D09205 |
Prucalopride |
3件: 13, 51, 96 |
| 1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 170 | Shigellosis 2 genes, 8 drugs (DrugBank) and 67 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 171 | Signaling pathways regulating pluripotency of stem cells 4 genes, 4 drugs (DrugBank) and 17 diseases shown |
1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 3件: JAK1, JAK2, JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 172 | Small cell lung cancer 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 173 | Sphingolipid signaling pathway 8 genes, 9 drugs (DrugBank) and 49 diseases shown |
1件: ADORA1 |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 1件: OPRD1 |
D02095 |
Naltrexone |
11件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97 |
| D05113 |
| 5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 |
D10968 |
Ozanimod |
3件: 13, 96, 97 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 174 | Staphylococcus aureus infection 15 genes, 2 drugs (DrugBank) and 11 diseases shown |
14件: HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 175 | Synaptic vesicle cycle 2 genes, 1 drug (DrugBank) and 2 diseases shown |
2件: SLC6A2, SLC6A3 |
D00817 |
Bupropion |
2件: 8, 96 |
| D07591 |
| D07938 |
| 176 | Systemic lupus erythematosus 20 genes, 10 drugs (DrugBank) and 55 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| 1件: ELANE |
D03788 |
Sivelestat |
3件: 13, 85, 96 |
| 2件: GRIN2A, GRIN2B |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| 14件: HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 177 | T cell receptor signaling pathway 11 genes, 11 drugs (DrugBank) and 57 diseases shown |
3件: CD3D, CD3E, CD3G |
D05092 |
Muromonab |
3件: 60, 96, 97 |
| D06314 |
Visilizumab |
2件: 96, 97 |
| 1件: CTLA4 |
D06657 |
Tremelimumab |
2件: 65, 96 |
| 1件: PDCD1 |
D10316 |
Nivolumab |
10件: 13, 26, 41, 46, 49, 50, 51, 53, 96, 97 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 178 | Taste transduction 11 genes, 4 drugs (DrugBank) and 17 diseases shown |
1件: CACNA1C |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 6件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 |
D00550 |
Midazolam |
10件: 2, 3, 6, 13, 46, 70, 96, 97, 231, 298 |
| D00696 |
| D05028 |
| 1件: PDE1B |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 3件: SCN2A, SCN3A, SCN9A |
D01450 |
Bupivacaine |
7件: 46, 53, 70, 96, 168, 226, 298 |
| D07552 |
| 179 | Terpenoid backbone biosynthesis 2 genes, 5 drugs (DrugBank) and 26 diseases shown |
1件: FDPS |
D00942 |
Risedronic acid |
7件: 46, 66, 93, 95, 96, 113, 274 |
| D03234 |
| D08484 |
| D01968 |
Zoledronic acid |
11件: 6, 13, 46, 65, 93, 95, 96, 271, 274, 299, 333 |
| D06378 |
| D06379 |
| D08689 |
| 1件: HMGCR |
D00887 |
Atorvastatin |
17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
| D07474 |
| D00893 |
Pravastatin |
9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 |
| D08410 |
| D01915 |
Rosuvastatin |
8件: 6, 46, 49, 51, 79, 96, 271, 299 |
| D08492 |
| 180 | TGF-beta signaling pathway 2 genes, 7 drugs (DrugBank) and 43 diseases shown |
1件: SMAD7 |
D10956 |
Mongersen |
2件: 96, 97 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 181 | Th1 and Th2 cell differentiation 28 genes, 8 drugs (DrugBank) and 40 diseases shown |
3件: CD3D, CD3E, CD3G |
D05092 |
Muromonab |
3件: 60, 96, 97 |
| D06314 |
Visilizumab |
2件: 96, 97 |
| 14件: HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 4件: JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 182 | Th17 cell differentiation 29 genes, 14 drugs (DrugBank) and 60 diseases shown |
3件: CD3D, CD3E, CD3G |
D05092 |
Muromonab |
3件: 60, 96, 97 |
| D06314 |
Visilizumab |
2件: 96, 97 |
| 14件: HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 1件: IL23A |
D10438 |
Guselkumab |
3件: 37, 96, 97 |
| D11123 |
Mirikizumab |
2件: 96, 97 |
| D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
| D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 4件: JAK1, JAK2, JAK3, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: RARA |
D01418 |
Tamibarotene |
2件: 26, 96 |
| 183 | Thermogenesis 4 genes, 5 drugs (DrugBank) and 55 diseases shown |
1件: ADRB3 |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| 1件: CNR1 |
D10915 |
Cannabidiol |
14件: 2, 6, 13, 46, 95, 96, 97, 140, 144, 145, 157, 158, 193, 271 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| 184 | Thyroid cancer 1 gene, 1 drug (DrugBank) and 17 diseases shown |
1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| 185 | Thyroid hormone signaling pathway 5 genes, 4 drugs (DrugBank) and 41 diseases shown |
1件: ESR1 |
D08409 |
Prasterone |
6件: 49, 53, 83, 86, 96, 113 |
| 3件: HDAC1, HDAC2, HDAC3 |
D06320 |
Vorinostat |
2件: 19, 96 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 186 | Tight junction 1 gene, 1 drug (DrugBank) and 4 diseases shown |
1件: CACNA1D |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 187 | TNF signaling pathway 2 genes, 7 drugs (DrugBank) and 47 diseases shown |
1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 188 | Toll-like receptor signaling pathway 7 genes, 10 drugs (DrugBank) and 53 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| 2件: IFNAR1, IFNAR2 |
D03305 |
Interferon alfa |
5件: 25, 26, 28, 56, 96 |
| D04554 |
Interferon beta-1a |
5件: 13, 14, 26, 96, 97 |
| 2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 189 | Toxoplasmosis 20 genes, 11 drugs (DrugBank) and 47 diseases shown |
14件: HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 3件: JAK1, JAK2, TYK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 190 | Transcriptional misregulation in cancer 8 genes, 8 drugs (DrugBank) and 39 diseases shown |
1件: CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| 1件: ELANE |
D03788 |
Sivelestat |
3件: 13, 85, 96 |
| 2件: HDAC1, HDAC2 |
D06320 |
Vorinostat |
2件: 19, 96 |
| 1件: IGF1R |
D03297 |
Mecasermin |
6件: 65, 78, 96, 168, 265, 299 |
| D04870 |
| 1件: ITGB7 |
D09901 |
Etrolizumab |
2件: 96, 97 |
| D08083 |
Vedolizumab |
2件: 96, 97 |
| 1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
| D08378 |
| 1件: RARA |
D01418 |
Tamibarotene |
2件: 26, 96 |
| 191 | Tuberculosis 26 genes, 19 drugs (DrugBank) and 63 diseases shown |
14件: HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 3件: IL12A, IL12B, IL23A |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: IL23A |
D10438 |
Guselkumab |
3件: 37, 96, 97 |
| D11123 |
Mirikizumab |
2件: 96, 97 |
| D11052 |
Risankizumab |
4件: 37, 96, 97, 271 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, JAK2 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 1件: VDR |
D01518 |
Alfacalcidol |
6件: 41, 46, 49, 50, 96, 235 |
| D00129 |
Calcitriol |
8件: 37, 46, 49, 66, 96, 158, 235, 326 |
| D00188 |
Cholecalciferol |
15件: 6, 13, 19, 20, 34, 46, 49, 53, 60, 65, 96, 97, 228, 298, 299 |
| D00187 |
Ergocalciferol |
5件: 46, 84, 96, 97, 299 |
| 192 | Type I diabetes mellitus 25 genes, 9 drugs (DrugBank) and 52 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 2件: IL12A, IL12B |
D09214 |
Ustekinumab |
16件: 13, 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 193 | Type II diabetes mellitus 5 genes, 10 drugs (DrugBank) and 71 diseases shown |
2件: CACNA1C, CACNA1D |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
| D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 194 | Ubiquinone and other terpenoid-quinone biosynthesis 2 genes, 1 drug (DrugBank) and 10 diseases shown |
2件: NQO1, VKORC1 |
D00564 |
Warfarin |
10件: 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
| D01280 |
| D08682 |
| 195 | Vascular smooth muscle contraction 9 genes, 4 drugs (DrugBank) and 28 diseases shown |
1件: ADORA2A |
D00528 |
Caffeine |
6件: 2, 6, 46, 78, 96, 97 |
| D01453 |
| 3件: ADRA1A, ADRA1B, ADRA1D |
D00095 |
Epinephrine |
9件: 6, 13, 46, 86, 96, 168, 226, 231, 256 |
| D00996 |
| D02149 |
| 1件: AGTR1 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00619 |
Verapamil |
4件: 96, 130, 140, 167 |
| D02356 |
| 196 | VEGF signaling pathway 6 genes, 2 drugs (DrugBank) and 36 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 1件: PTGS2 |
D00567 |
Celecoxib |
9件: 2, 3, 34, 46, 70, 89, 96, 161, 271 |
| 197 | Viral carcinogenesis 19 genes, 5 drugs (DrugBank) and 16 diseases shown |
11件: HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9 |
D06320 |
Vorinostat |
2件: 19, 96 |
| 6件: HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 1件: JAK1 |
D10871 |
Filgotinib |
6件: 46, 53, 96, 97, 222, 271 |
| D10994 |
Upadacitinib |
6件: 41, 46, 49, 96, 97, 271 |
| 2件: JAK1, JAK3 |
D09970 |
Tofacitinib |
9件: 46, 49, 50, 51, 84, 96, 97, 107, 271 |
| 198 | Viral myocarditis 23 genes, 3 drugs (DrugBank) and 29 diseases shown |
2件: CD80, CD86 |
D03203 |
Abatacept |
24件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 96, 97, 107, 164, 222, 271, 284, 285, 300 |
| 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 199 | Viral protein interaction with cytokine and cytokine receptor 1 gene, 6 drugs (DrugBank) and 43 diseases shown |
1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |
| 200 | Wnt signaling pathway 5 genes, 1 drug (DrugBank) and 30 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 201 | Yersinia infection 2 genes, 8 drugs (DrugBank) and 47 diseases shown |
1件: ITGA4 |
D06886 |
Natalizumab |
6件: 13, 15, 25, 46, 63, 96 |
| D08083 |
Vedolizumab |
2件: 96, 97 |
| 1件: TNF |
D02597 |
Adalimumab |
15件: 19, 37, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 |
| D03441 |
Certolizumab pegol |
6件: 37, 46, 96, 97, 226, 271 |
| D04358 |
Golimumab |
5件: 46, 84, 96, 97, 271 |
| D02598 |
Infliximab |
23件: 35, 37, 38, 39, 40, 41, 43, 45, 46, 49, 50, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 |
| D04687 |
Lenalidomide |
8件: 16, 26, 28, 34, 49, 96, 284, 300 |
| D00754 |
Thalidomide |
18件: 2, 16, 20, 28, 49, 51, 53, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 331 |